Original Paper: Prevalence of the Metabolic Syndrome in Patients With Acute Coronary Syndrome in Six Middle Eastern Countries (original) (raw)
Related papers
Journal of Clinical Hypertension, 2010
J Clin Hypertens (Greenwich).The objective of this study was to evaluate the prevalence and effect of the metabolic syndrome (MetS) on patients with acute coronary syndrome (ACS) in six Middle Eastern countries using the new definition of MetS. Analysis of the Gulf Registry of Acute Coronary Events (Gulf RACE), which included 8716 consecutive patients hospitalized with ACS, was conducted and patients were divided into two groups: patients with and patients without the MetS. Overall, 46% of patients had MetS. Patients with MetS were more likely to be female and less likely to be smokers. In-hospital mortality and cardiogenic shock were comparable between the two groups, although MetS patients were more likely to have congestive heart failure and recurrent ischemia. In ST-elevation myocardial infarction, MetS was also associated with increased risk of recurrent myocardial infarction and stroke. Using the recent MetS definition, MetS is highly prevalent among Middle Eastern patients presenting with ACS. MetS is associated with higher-risk profile characteristics and increased risk for development of heart failure and recurrent myocardial ischemia without an increase in hospital mortality. J Clin Hypertens (Greenwich). 2010;12:890–899.
Journal of the Faculty of Medicine Baghdad
Background: The demographic characteristics of Iraqi patients with the metabolic syndrome (MS) and presenting with acute coronary syndrome (ACS) has been scarcely studied before. Aim of the study To study the socio-demographic characteristics of a group of Iraqi patients with MS presenting with ACS. Patients and Methods: A convenience sample of 150 cases presenting with ACS and admitted to the coronary care unit (CCU) of Al-Yarmouk Teaching Hospital in Baghdad from mid-January through July 2011 were included in the current cross-sectional study. The data needed for the study was collected through a direct interview to fill a questionnaire by all cases carried out by a consultant physician.
The Scientific World JOURNAL, 2009
Metabolic syndrome (MS) is associated with an increased risk of coronary artery disease (CAD) in Western populations. We have investigated the relationship between the presence of MS and other conventional risk factors, and angiographically defined CAD, in a Middle Eastern population. Patients (n = 431) attending a hospital cardiology clinic for angiography were assessed. Each patient subsequently underwent routine angiography. Anthropometric and biochemical data were used to establish whether patients had MS, using either IDF or NCEP-ATP III criteria. The relationship between the presence of MS, or other individual coronary risk factors, and angiographically defined CAD was assessed by logistic regression analysis. A further reference group of individuals without overt CAD (n = 1276) was used as an additional comparator group. Of the 431 patients, 327 (75.9%) were found to have angiographically defined CAD. There was no significant relationship between MS, using either the IDF or N...
International Journal of Advances in Medicine, 2019
Background: Several components of the Metabolic Syndrome (MetS) are risk factor for cardiovascular diseases. So, this study was conducted to evaluate the prevalence of MetS and its components in patients with CAD.Methods: Author included all patients admitted with Acute Coronary Syndrome (ACS), who had CAD confirmed by coronary angiography. They were divided into two groups according to presence or absence of MetS based on International Diabetes Federation criteria. The prevalence of MetS and its individual components was estimated.Results: It was observed that there is a high prevalence of MetS (66%) in patients admitted with ACS. Metabolic syndrome is more prevalent in female patients (82.4%) than in male patients (57.6%) with ACS. Hypertension is the most prevalent (87.9) component of MetS. Diabetes Mellitus (DM) is the 2nd most prevalent (83.3%) component of MetS. About 65.2% patients with MetS had abnormally raised triglyceride levels and 32(48.5%) had abnormally low HDL-choles...
Background: Metabolic syndrome describes clustering of factors including dyslipidemia, glucose intolerance and hypertension with central obesity. The metabolic syndrome has a marked impact on the prevalence of cardiovascular disease and type 2 diabetes worldwide. The prevalence of metabolic syndrome is increasing worldwide & in Bangladesh, the prevalence of metabolic syndrome by using ATP III criteria was found to be 20.7 % for both men and women. Objective: To find out the relation between metabolic syndrome and acute coronary syndrome. Methods: The study was a hospital-based observational study conducted at the cardiology department, Sir Salimullah Medical College and Mitford Hospital. A sample of 200 adults was recruited (group 1-100 patients with ACS, group 2-100 subjects with no evidence of CAD). Participants were interviewed on their personal medical history. Blood pressure and anthropometric measurements were taken by using standardized methods. Blood samples were collected in a fasting state to measure triglyceride, FBG and HDL-C. For this study, the ATP criteria IV was used to describe the metabolic syndrome. Results: The prevalence of metabolic syndrome in ACS patients admitted in the hospital was 46% using ATP IV criteria, however, it was lower among subjects with no evidence of CAD (26%). The most prevalent risk factor was low HDL-C followed by elevated TG, hypertension, glucose intolerance and obesity. Hypertension, increased TG and impaired fasting glucose levels were predominant among patients with ACS. Dyslipidemia was identified as the most frequent and obesity was the least frequent component of metabolic syndrome. Conclusions: The study revealed that metabolic syndrome is highly prevalent in patients with acute coronary syndrome. This provides an opportunity for preventive strategies, reinforcing the good practices and learning the advantages of maintaining them to lower the clustering of potential risks for cardiovascular diseases.